Pacific Biosciences of California PACB Business Segments — Merger-related expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationAcquisitionRelatedCosts.
The official record: Pacific Biosciences of California’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's business segments — merger-related expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's business segments — merger-related expenses?
- Pacific Biosciences of California (PACB) reported business segments — merger-related expenses of $0 in Q4 2025.
- What does business segments — merger-related expenses mean?
- These are non-recurring costs incurred by the reportable segment specifically associated with the acquisition or integration of other business entities. Such expenses may include legal fees, consulting costs, and integration-related personnel expenses. Identifying these costs allows investors to isolate the impact of inorganic growth strategies from the segment's core operational performance.